Split History
ETFs Holding DMTK »    DMTK Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
DermTech is a molecular diagnostic company developing and marketing non-invasive genomics tests to aid in the diagnosis and management of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. Co.'s focus is skin cancer. Co. provides the DermTech Melanoma Test for the early detection of melanoma and is developing a product for non-melanoma skin cancer. Co. is also working on products to assess precancerous genomic changes associated with sun UV exposure to the skin. Co. has additional skin cancer product offerings, including for non-melanoma skin cancers (basal cell and squamous cell cancers), under development. According to our DMTK split history records, DermTech has had 1 split.
DMTK split history picture
DermTech (DMTK) has 1 split in our DMTK split history database. The split for DMTK took place on August 30, 2019. This was a 1 for 2 reverse split, meaning for each 2 shares of DMTK owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 500 share position following the split.

When a company such as DermTech conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the DMTK split history from start to finish, an original position size of 1000 shares would have turned into 500 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into DermTech shares, starting with a $10,000 purchase of DMTK, presented on a split-history-adjusted basis factoring in the complete DMTK split history. DMTK split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 08/11/2017
End date: 12/06/2022
Start price/share: $19.40
End price/share: $2.30
Dividends collected/share: $0.00
Total return: -88.14%
Average Annual Total Return: -33.01%
Starting investment: $10,000.00
Ending investment: $1,185.23
Years: 5.32
Date Ratio
08/30/20191 for 2
DMTK is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

DRAD Split History
DRRX Split History
DSCI Split History
DSCO Split History
DVA Split History
DVAX Split History
DXCM Split History
DYN Split History
DYNT Split History
EAR Split History

Also explore: DMTK shares outstanding history

Email EnvelopeFree DMTK Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Checkpoint Therapeutics, Inc. (CKPT)
UpHealth, Inc. (UPH)
MediWound Ltd. (MDWD)
Eloxx Pharmaceuticals, Inc. (ELOX)
Baudax Bio, Inc. (BXRX)
Petros Pharmaceuticals, Inc. (PTPI)
Tuesday Morning Corporation (TUEM)
DURECT Corporation (DRRX)
CNS Pharmaceuticals, Inc. (CNSP)
Astrotech Corporation (ASTC)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

DMTK Insider Buying

DMTK Split History | www.SplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.